Gilead Sciences (GILD) Operating Expenses (2009 - 2026)
Gilead Sciences posted quarterly Operating Expenses of $4.4 billion for Q1 2026, down 1.26% year-on-year from $4.4 billion in Q1 2025, and down 26.38% on a QoQ basis from $5.9 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Operating Expenses data on file, last reported at $4.4 billion in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses fell 1.26% year-over-year to $4.4 billion; the trailing twelve-month figure through Mar 2026 stood at $19.4 billion (down 5.6% YoY), and the FY2025 full-year result was $19.4 billion, down 28.31% from the prior year.
- Operating Expenses for Q1 2026 stood at $4.4 billion, down from $5.9 billion in the prior quarter.
- Across five years, Operating Expenses topped out at $11.0 billion in Q1 2024 and bottomed at $4.2 billion in Q3 2022.
- The 5-year median for Operating Expenses is $4.6 billion (2023), against an average of $5.3 billion.
- The widest annual swing landed in 2024, when Operating Expenses soared 136.88%; it then sank 59.76% in 2025.
- A 5-year view of Operating Expenses shows it stood at $5.1 billion in 2022, then grew by 7.42% to $5.5 billion in 2023, then fell by 7.0% to $5.1 billion in 2024, then rose by 16.1% to $5.9 billion in 2025, then dropped by 26.38% to $4.4 billion in 2026.
- The last three Operating Expenses figures came in at $4.4 billion (Q1 2026), $5.9 billion (Q4 2025), and $4.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 6.72 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 9.59 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 11.01 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 19.82 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 5.95 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 4.37 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 5.50 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 8.25 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.37 Bn |
| Dec 31, 2025 | 5.94 Bn |
| Sep 30, 2025 | 4.44 Bn |
| Jun 30, 2025 | 4.61 Bn |
| Mar 31, 2025 | 4.43 Bn |
| Dec 31, 2024 | 5.12 Bn |
| Sep 30, 2024 | 6.66 Bn |
| Jun 30, 2024 | 4.31 Bn |
| Mar 31, 2024 | 11.01 Bn |
| Dec 31, 2023 | 5.50 Bn |
| Sep 30, 2023 | 4.43 Bn |
| Jun 30, 2023 | 4.93 Bn |
| Mar 31, 2023 | 4.65 Bn |
| Dec 31, 2022 | 5.12 Bn |
| Sep 30, 2022 | 4.21 Bn |
| Jun 30, 2022 | 4.23 Bn |
| Mar 31, 2022 | 6.39 Bn |
| Dec 31, 2021 | 6.30 Bn |
| Sep 30, 2021 | 3.58 Bn |
| Jun 30, 2021 | 3.97 Bn |
| Mar 31, 2021 | 3.53 Bn |
| Dec 31, 2020 | 4.77 Bn |
| Sep 30, 2020 | 4.58 Bn |
| Jun 30, 2020 | 8.13 Bn |
| Mar 31, 2020 | 3.15 Bn |
| Dec 31, 2019 | 4.79 Bn |
| Sep 30, 2019 | 7.08 Bn |
| Jun 30, 2019 | 3.26 Bn |
| Mar 31, 2019 | 3.04 Bn |
| Dec 31, 2018 | 4.65 Bn |
| Sep 30, 2018 | 2.97 Bn |
| Jun 30, 2018 | 3.37 Bn |
| Mar 31, 2018 | 2.94 Bn |
| Dec 31, 2017 | 3.66 Bn |
| Sep 30, 2017 | 2.70 Bn |
| Jun 30, 2017 | 2.89 Bn |
| Mar 31, 2017 | 2.74 Bn |
| Dec 31, 2016 | 3.28 Bn |
| Sep 30, 2016 | 3.10 Bn |
| Jun 30, 2016 | 3.24 Bn |
| Mar 31, 2016 | 3.14 Bn |
| Dec 31, 2015 | 2.89 Bn |
| Sep 30, 2015 | 2.71 Bn |
| Jun 30, 2015 | 2.63 Bn |
| Mar 31, 2015 | 2.22 Bn |
| Dec 31, 2014 | 2.98 Bn |
| Sep 30, 2014 | 2.56 Bn |
| Jun 30, 2014 | 2.12 Bn |
| Mar 31, 2014 | 1.96 Bn |
| Dec 31, 2013 | 1.92 Bn |
| Sep 30, 2013 | 1.63 Bn |
| Jun 30, 2013 | 1.61 Bn |
| Mar 31, 2013 | 1.51 Bn |
| Dec 31, 2012 | 1.48 Bn |
| Sep 30, 2012 | 1.38 Bn |
| Jun 30, 2012 | 1.35 Bn |
| Mar 31, 2012 | 1.48 Bn |
| Dec 31, 2011 | 1.33 Bn |
| Sep 30, 2011 | 1.12 Bn |
| Jun 30, 2011 | 1.12 Bn |
| Mar 31, 2011 | 1.02 Bn |
| Dec 31, 2010 | 1.17 Bn |
| Sep 30, 2010 | 958.58 Mn |
| Jun 30, 2010 | 934.60 Mn |
| Mar 31, 2010 | 924.71 Mn |
| Dec 31, 2009 | 966.94 Mn |
| Sep 30, 2009 | 906.98 Mn |
| Jun 30, 2009 | 886.09 Mn |
| Mar 31, 2009 | 722.14 Mn |